Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,661 across all filing types
Latest filing 2020-11-02 Board/Management Inform…
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2020 ,inter alia, to consider and approve the Un-audited Financial ....
Board/Management Information Classification · 95% confidence The document is a notice of a Board Meeting scheduled to consider and approve the company's quarterly and half-year financial results. It is addressed to stock exchanges and mentions compliance with SEBI regulations. The document does not contain actual financial data or results but is an announcement of the meeting where such results will be approved. The document length is short (1817 characters), and it serves as an intimation rather than a report itself. Therefore, it fits the category of Board/Management Information (MANG), which includes announcements of board meetings and related management information.
2020-11-02 English
Board Meeting — Financial Results
Regulatory Filings Classification · 100% confidence The document text is extremely short (82 characters) and contains no substantive content, only placeholders and omitted images. There is no financial data, no report content, no announcements, or any other information to classify as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2020-11-02 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is very short (1105 characters) and consists mainly of a table listing issuance of duplicate share certificates to shareholders upon request. There is no financial data, no discussion of company performance, no regulatory or legal content, and no mention of meetings or votes. The content is administrative and relates to share certificate issuance. This does not fit into any detailed report category such as Annual Report, Earnings Release, or Management Reports. It is not a director's dealing or major shareholding notification since it concerns duplicate certificates, not share transactions or ownership changes. The document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit other categories.
2020-11-02 English
Morepen Laboratories Limited has informed BSE about the issuance of duplicate share certificate and Loss of Share Certificates of the Company
Share Issue/Capital Change Classification · 95% confidence The document is an official communication addressed to stock exchanges (NSE and BSE) regarding the issuance of duplicate share certificates and the loss of share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management and shareholder information disclosures. The content includes detailed lists of share certificates issued as duplicates and lost certificates reported by shareholders. There is no financial data, earnings information, management discussion, or report publication mentioned. The document is an announcement related to share certificate status and shareholder record updates, which fits the category of Share Issue/Capital Change (SHA) as it deals with changes in share certificates and capital records rather than a financial report or regulatory filing. The document length is about 4898 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the best classification is SHA with high confidence.
2020-11-02 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (National Stock Exchange of India Ltd. and Bombay Stock Exchange Limited) regarding the loss of share certificates by shareholders and the request for issuance of duplicate share certificates. It references Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and related disclosures. The content is about notifying the stock exchanges of these events, not about financial results, management changes, or other report types. The document is not a financial report, earnings release, or management discussion. It is a regulatory announcement related to share certificates and shareholder information. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-10-30 English
Morepen Laboratories Limited has informed BSE about the Loss of Share Certificates of the Company
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (NSE and BSE) regarding the loss of share certificates by shareholders and the request for issuance of duplicate share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to reporting such events. The content is about notifying the stock exchanges of these losses and related administrative actions, not about financial results, management changes, or other report types. The document is not a financial report, earnings release, or management discussion. It is a regulatory announcement related to share certificates. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-10-30 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.